Intellia Therapeutics Inc (NAS:NTLA)
$ 22.94 -0.64 (-2.71%) Market Cap: 2.33 Bil Enterprise Value: 1.75 Bil PE Ratio: 0 PB Ratio: 2.39 GF Score: 69/100

Intellia Therapeutics Inc (NTLA) Transcripts

  • 1